IL99434A - H) -3-Indazol-3-yl (-4-pyridinamines Process for their preparation and pharmaceutical preparations containing them - Google Patents
H) -3-Indazol-3-yl (-4-pyridinamines Process for their preparation and pharmaceutical preparations containing themInfo
- Publication number
- IL99434A IL99434A IL9943491A IL9943491A IL99434A IL 99434 A IL99434 A IL 99434A IL 9943491 A IL9943491 A IL 9943491A IL 9943491 A IL9943491 A IL 9943491A IL 99434 A IL99434 A IL 99434A
- Authority
- IL
- Israel
- Prior art keywords
- hydrogen
- compound
- indazol
- loweralkyl
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/579,751 US5051430A (en) | 1990-09-10 | 1990-09-10 | 3-(1H-indazol-3-yl)-4-pyridinamines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL99434A0 IL99434A0 (en) | 1992-08-18 |
| IL99434A true IL99434A (en) | 1995-08-31 |
Family
ID=24318208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9943491A IL99434A (en) | 1990-09-10 | 1991-09-06 | H) -3-Indazol-3-yl (-4-pyridinamines Process for their preparation and pharmaceutical preparations containing them |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5051430A (no) |
| EP (1) | EP0475352B1 (no) |
| JP (1) | JP3042915B2 (no) |
| KR (1) | KR100203236B1 (no) |
| AT (1) | ATE123493T1 (no) |
| AU (1) | AU640590B2 (no) |
| CA (1) | CA2050875C (no) |
| CZ (1) | CZ280883B6 (no) |
| DE (1) | DE69110219T2 (no) |
| DK (1) | DK0475352T3 (no) |
| ES (1) | ES2074618T3 (no) |
| FI (1) | FI914219A (no) |
| HU (1) | HUT59126A (no) |
| IE (1) | IE67442B1 (no) |
| IL (1) | IL99434A (no) |
| NO (1) | NO913543L (no) |
| NZ (1) | NZ239692A (no) |
| PL (1) | PL295728A1 (no) |
| PT (1) | PT98911B (no) |
| ZA (1) | ZA917141B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT56347A (en) * | 1989-12-27 | 1991-08-28 | Hoechst Roussel Pharma | Process for producing aminopyridinylmethanol and aminomethyl pyridineamine derivatives and pharmaceutical compositions comprising such compounds |
| US6897231B2 (en) | 2000-07-31 | 2005-05-24 | Signal Pharmaceuticals, Inc. | Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| US7211594B2 (en) | 2000-07-31 | 2007-05-01 | Signal Pharmaceuticals, Llc | Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| WO2002083648A1 (en) * | 2001-04-16 | 2002-10-24 | Eisai Co., Ltd. | Novel 1h-indazole compound |
| EP1720855A4 (en) * | 2004-03-02 | 2008-12-17 | Smithkline Beecham Corp | HEMMER OF ACT ACTIVITY |
| CN101213191B (zh) * | 2005-03-30 | 2011-08-24 | （株）大熊制药 | 抗真菌三唑衍生物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU198036B (en) * | 1983-08-22 | 1989-07-28 | Hoechst Roussel Pharma | Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them |
-
1990
- 1990-09-10 US US07/579,751 patent/US5051430A/en not_active Expired - Fee Related
-
1991
- 1991-09-06 FI FI914219A patent/FI914219A/fi not_active Application Discontinuation
- 1991-09-06 CA CA002050875A patent/CA2050875C/en not_active Expired - Fee Related
- 1991-09-06 IL IL9943491A patent/IL99434A/en unknown
- 1991-09-06 NZ NZ239692A patent/NZ239692A/en unknown
- 1991-09-09 PL PL29572891A patent/PL295728A1/xx unknown
- 1991-09-09 PT PT98911A patent/PT98911B/pt not_active IP Right Cessation
- 1991-09-09 IE IE315791A patent/IE67442B1/en not_active IP Right Cessation
- 1991-09-09 HU HU912901A patent/HUT59126A/hu unknown
- 1991-09-09 AU AU83716/91A patent/AU640590B2/en not_active Expired - Fee Related
- 1991-09-09 JP JP3227982A patent/JP3042915B2/ja not_active Expired - Lifetime
- 1991-09-09 CZ CS912776A patent/CZ280883B6/cs not_active IP Right Cessation
- 1991-09-09 NO NO91913543A patent/NO913543L/no unknown
- 1991-09-09 ZA ZA917141A patent/ZA917141B/xx unknown
- 1991-09-10 EP EP91115280A patent/EP0475352B1/en not_active Expired - Lifetime
- 1991-09-10 AT AT91115280T patent/ATE123493T1/de not_active IP Right Cessation
- 1991-09-10 DE DE69110219T patent/DE69110219T2/de not_active Expired - Fee Related
- 1991-09-10 DK DK91115280.9T patent/DK0475352T3/da active
- 1991-09-10 ES ES91115280T patent/ES2074618T3/es not_active Expired - Lifetime
- 1991-09-10 KR KR1019910015736A patent/KR100203236B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69110219D1 (de) | 1995-07-13 |
| IE67442B1 (en) | 1996-04-03 |
| JPH04247079A (ja) | 1992-09-03 |
| NZ239692A (en) | 1994-01-26 |
| IE913157A1 (en) | 1992-03-11 |
| ZA917141B (en) | 1992-04-29 |
| FI914219A (fi) | 1992-03-11 |
| CA2050875C (en) | 2002-07-16 |
| KR920006346A (ko) | 1992-04-27 |
| NO913543L (no) | 1992-03-11 |
| ATE123493T1 (de) | 1995-06-15 |
| ES2074618T3 (es) | 1995-09-16 |
| PT98911A (pt) | 1992-07-31 |
| PL295728A1 (en) | 1993-05-04 |
| KR100203236B1 (ko) | 1999-06-15 |
| DE69110219T2 (de) | 1995-11-09 |
| EP0475352B1 (en) | 1995-06-07 |
| AU640590B2 (en) | 1993-08-26 |
| CA2050875A1 (en) | 1992-03-11 |
| IL99434A0 (en) | 1992-08-18 |
| AU8371691A (en) | 1992-03-12 |
| PT98911B (pt) | 1999-02-26 |
| DK0475352T3 (da) | 1995-10-16 |
| CS277691A3 (en) | 1992-04-15 |
| HUT59126A (en) | 1992-04-28 |
| HU912901D0 (en) | 1992-01-28 |
| NO913543D0 (no) | 1991-09-09 |
| JP3042915B2 (ja) | 2000-05-22 |
| CZ280883B6 (cs) | 1996-04-17 |
| US5051430A (en) | 1991-09-24 |
| EP0475352A1 (en) | 1992-03-18 |
| FI914219A0 (fi) | 1991-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230312557A1 (en) | P2x3 modulators | |
| AU635150B2 (en) | 4-substituted dihydropyrido(4,3-d)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders | |
| US5051430A (en) | 3-(1H-indazol-3-yl)-4-pyridinamines | |
| KR900003368B1 (ko) | 신규한 인데노티아졸 유도체의 제조방법 | |
| JPH0674264B2 (ja) | １―（ピリジニルアミノ）―２―ピロリジノンおよびその製造法 | |
| US5055476A (en) | 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives | |
| US5166163A (en) | 3-(1H-indazol-3-yl)-4-pyridinamines | |
| US5109011A (en) | P-acylaminophenoxycarbamates and derivatives | |
| US4438121A (en) | Isoquinoline amidoxime derivatives | |
| US4477465A (en) | Substituted 4,10-dihydro-10-oxothieno benzoxepins | |
| JP3090500B2 (ja) | ピリド〔３，４−ｂ〕ピロロ〔１，２−ｅ〕〔１，４，５〕オキサジアゼピンおよび関連する同族体 | |
| US4038281A (en) | Certain 2,7-dihydro-4H-pyrazolo[3,4-b]pyridine-5-ketones | |
| CZ658590A3 (en) | Aminopyridinylmethanols, aminomethylpyridinamines and their derivatives, process of their preparation, pharmaceutical composition containing such compounds and use thereof | |
| JPH0395182A (ja) | ドパミンアゴニスト | |
| JPH0649067A (ja) | ４，５−ジヒドロピラゾロ〔３，４−ａ〕アクリジン類、それらの製造方法および医薬としてのそれらの使用 | |
| US5214061A (en) | Method of using p-acylaminophenoxycarbamates and derivatives as analgesics | |
| PL149608B1 (en) | A method of obtaining new derivatives of benzothiazine dioxide | |
| JPS63115859A (ja) | ２−ピロリドン誘導体を含有する抗炎症剤 | |
| JPS5948489A (ja) | ２Ｈ−ピリド〔３，２−ｂ〕−１，４−オキサジン誘導体およびそれを含有する鎮痛組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of name of proprietor(s) | ||
| KB | Patent renewed | ||
| KB | Patent renewed |